Delivery Order SPE2DB22D9304-SPE2DB25FSSW1

Award Date 6/9/25
Potential Completion Date 6/10/25
Potential Value $18K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $19,316.57, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of TRIKAFTA 100-50-75 MG/75MG PKT 14S, a pharmaceutical product, with a period of performance through April 16, 2025. DMS Pharmaceutical Group Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at $499,999,999 and valid through November...
This federal contract award, valued at $18,526.83, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of a pharmaceutical product called TRIKAFTA 100-50-75 MG/150 MG UU 84S. This award is part of a larger indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $18,526.83 firm fixed-price delivery order is for the supply of TRIKAFTA 100-50-75 MG/150 MG UU 84S, a pharmaceutical product. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This single-award...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, worth up to $74,107.32, is for the delivery of TRIKAFTA 100-50-75 MG/75MG PKT 14S, a pharmaceutical product, with a completion date of May 8, 2024. This is a firm fixed-price delivery order contract, and there is no set-aside designation. DMS Pharmaceutical Group holds a significant...
This federal contract award, valued at $74,107.32, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of TRIKAFTA 100-50-75 MG/150 MG, a specialized pharmaceutical product, to support the recurring medical supply needs of military healthcare facilities. DMS Pharmaceutical Group Inc. holds a larger Indefinite...
This federal contract award, valued at $18,488.12, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order for the pharmaceutical product TRIKAFTA 100-50-75 MG/150 MG UU 84S, with a completion date of May 5, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at $499,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $18,526.83 firm fixed-price delivery order is for TRIKAFTA 80-40-60MG/59.5MG PKT 14S, a specialized pharmaceutical product. DMS Pharmaceutical Group holds a $499,999,999 single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue delivery...
This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $18,488.12, is a delivery order placed by the Defense Logistics Agency (DLA) for the supply of TRIKAFTA 100-50-75 MG/150 MG UU 84S. The contract has a firm fixed price and an ultimate completion date of May 20, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing...
The U.S. Defense Logistics Agency (DLA) awarded a $18,526.83 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the pharmaceutical product TRIKAFTA 80-40-60MG/59.5MG PKT 14S, with a period of performance through July 2, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with DLA to provide a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $68,514.54 firm fixed-price delivery order is for the supply of the drug TRIKAFTA 100-50-75 MG/150 MG, with a performance period through August 2, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the...
  • SPE2DB22D9304
    Indefinite Delivery Contract
  • SPE2DB22D9304-SPE2DB25FSSW1
    Delivery Order

This federal contract award, valued at $18,488.12, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the pharmaceutical product "TRIKAFTA 100-50-75 MG/150 MG UU 84S", with a completion date of June 10, 2025.

DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide. This contract award demonstrates DMS Pharmaceutical Group's positioning as a crucial supplier in the federal pharmaceutical supply chain, providing direct distribution of prescription drugs and pharmacy services to Department of Defense healthcare sites.

Generated 9/14/25, 1:07 AM